Abstract
Breast cancer is the commonest cancer in Africa. Although the incidence of breast cancer in Africa is relatively low compared to the western societies, its morbidity is enormous and the mortality from it is disproportionately high. The risk factors for breast cancer in Africa are similar to those in other populations. As in those populations, genetic epidemiological studies have also identified high- and low-penetrance genetic alterations in African women with breast cancer. In the absence of screening programmes, breast cancer in Africa presents with palpable tumours, axillary node involvement and distant metastases. Although pathology services are available in many tertiary centres, regionalisation of services will improve access to advanced techniques like immunohistochemistry. The multimodality management of breast cancer is best provided by an interdisciplinary team of specialists in a designated breast oncology service. There is therefore an urgent need to develop care paradigms that take advantage of existing resources and utilise them in innovative ways to provide resource-level-appropriate cancer care. Training, personnel and infrastructure for multisite studies and clinical trials are sorely lacking, and these need to be developed to improve the outlook of breast cancer in Africa in the near future.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
International Agency for Research on Cancer (2015) Globocan 2012: estimated cancer incidence, mortality and prevalence worldwide. IARC Press, Lyon. Available at: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx
Akarolo-Anthony SN, Ogundiran TO, Adebamowo CA (2010) Emerging breast cancer epidemic: evidence from Africa. Breast Cancer Res 12(Suppl 4):S8
Schatzkin A, Palmer JR, Rosenberg L, Helmrich SP, Miller DR, Kaufman DW, Lesko SM, Shapiro S (1987) Risk factors for breast cancer in black women. J Natl Cancer Inst 78(2):213–217
Adebamowo CA, Adekunle OO (1999) Case-controlled study of the epidemiological risk factors for breast cancer in Nigeria. Br J Surg 86(5):665–668
Adebamowo CA, Ogundiran TO, Adenipekun AA, Oyesegun RA, Campbell OB, Akang EU, Rotimi CN, Olopade OI (2003) Obesity and height in urban Nigerian women with breast cancer. Ann Epidemiol 13(6):455–461
Huo D, Adebamowo CA, Ogundiran TO, Akang EE, Campbell O, Adenipekun A, Cummings S, Fackenthal J, Ademuyiwa F, Ahsan H, Olopade OI (2008) Parity and breastfeeding are protective against breast cancer in Nigerian women. Br J Cancer 98(5):992–996
Ogundiran TO, Huo D, Adenipekun A, Campbell O, Oyesegun R, Akang E, Adebamowo C, Olopade OI (2012) Body fat distribution and breast cancer risk: findings from the Nigerian breast cancer study. Cancer Causes Control 23(4):565–574. doi:10.1007/s10552-012-9916-y, Epub 2012 Feb 25
Anyanwu SN (2000) Breast cancer in eastern Nigeria: a ten year review. West Afr J Med 19(2):120–125
Qian F, Ogundiran T, Hou N, Ndom P, Gakwaya A, Jombwe J, Morhason-Bello I, Adebamowo C, Ademola A, Ojengbede O, Olopade OI, Huo D (2014) Alcohol consumption and breast cancer risk among women in three sub-Saharan African countries. PLoS One 9(9), e106908. doi:10.1371/journal.pone.0106908. eCollection 2014
Hou N, Ndom P, Jombwe J, Ogundiran T, Ademola A, Morhason-Bello I, Ojengbede O, Gakwaya A, Huo D (2014) An epidemiologic investigation of physical activity and breast cancer risk in Africa. Cancer Epidemiol Biomarkers Prev 23(12):2748–2756. doi:10.1158/1055-9965.EPI-14-0675, Epub 2014 Sep 21
Fregene A, Newman LA (2005) Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American. Cancer 103:1540–1550
Gao Q, Adebamowo CA, Fackenthal J, Das S, Sveen L, Falusi AG, Olopade OI (2000) Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer. Hum Genet 107(2):192–194
Fackenthal JD, Zhang J, Zhang B, Zheng Y, Hagos F, Burrill DR, Niu Q, Huo D, Sveen WE, Ogundiran T, Adebamowo C, Odetunde A, Falusi AG, Olopade OI (2012) High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients. Int J Cancer 131(5):1114–1123. doi:10.1002/ijc.27326, Epub 2012 Jan 27
Tazzite A, Nadiffi S, Kottwitz D, El Amrani M, Jouhadi H, Benider A, Moumen A, Sefrioui H (2014) Specific BRCA1 gene variations amongst young Moroccan breast cancer patients. Genet Mol Res 13(1):791–798. doi:10.4238/2014.January.31.5
Cherbal F, Bakour R, Adane S, Boualga K, Benais-Pont G, Maillet P (2010) BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families. Dis Markers 28(6):377–384. doi:10.3233/DMA-2010-0718
Chen F, Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Palmer JR, Hu JJ, Rebbeck TR, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, Ruiz-Narvaez EA, Deming SL, Rodriguez-Gil JL, Demichele A, Chanock SJ, Blot W, Signorello L, Cai Q, Li G, Long J, Huo D, Zheng Y, Cox NJ, Olopade OI, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Simon MS, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, Hutter CM, Young A, Kooperberg C, Peters U, Rhie SK, Wan P, Sheng X, Pooler LC, Van Den Berg DJ, Le Marchand L, Kolonel LN, Henderson BE, Haiman CA (2013) A genome-wide association study of breast cancer in women of African ancestry. Hum Genet 132(1):39–48
Zheng Y, Ogundiran TO, Falusi AG, Nathanson KL, John EM, Hennis AJ, Ambs S, Domchek SM, Rebbeck TR, Simon MS, Nemesure B, Wu SY, Leske MC, Odetunde A, Niu Q, Zhang J, Afolabi C, Gamazon ER, Cox NJ, Olopade CO, Olopade OI, Huo D (2013) Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers. Carcinogenesis 34(7):1520–1528
Shan J, Mahfoudh W, Dsouza SP, Hassen E, Bouaouina N, Abdelhak S, Benhadjayed A, Memmi H, Mathew RA, Aigha II, Gabbouj S, Remadi Y, Chouchane L (2012) Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians. Breast Cancer Res Treat 135(3):715–724. doi:10.1007/s10549-012-2202-6, Epub 2012 Aug 22
Adebamowo CA, Ajayi OO (2000) Breast cancer in Nigeria. West Afr J Med 19(3):179–191, Review
Hou N, Ogundiran T, Ojengbede O, Morhason-Bello I, Zheng Y, Fackenthal J, Adebamowo C, Anetor I, Akinleye S, Olopade OI, Huo D (2013) Risk factors for pregnancy-associated breast cancer: a report from the Nigerian Breast Cancer Study. Ann Epidemiol 23(9):551–557. doi:10.1016/j.annepidem.2013.06.008, Epub 2013 Jul 20
Burson AM, Soliman AS, Ngoma TA, Mwaiselage J, Ogweyo P, Eissa MS, Dey S, Merajver SD (2010) Clinical and epidemiologic profile of breast cancer in Tanzania. Breast Dis 31(1):33–41. doi:10.3233/BD-2009-0296
Ohene-Yeboah M, Adjei E (2012) Breast cancer in Kumasi. Ghana Ghana Med J 46(1):8–13
Adebamowo CA (2000) Topical formalin for management of bleeding malignant ulcers. World J Surg 24(5):518–520
Jeremic B, Vanderpuye V, Abdel-Wahab S, Gaye P, Kochbati L, Diwani M, Emwula P, Oro B, Lishimpi K, Kigula-Mugambe J, Dawotola D, Wondemagegnehu T, Nyongesa C, Oumar N, El-Omrani A, Shuman T, Langenhoven L, Fourie L (2014) Patterns of practice in palliative radiotherapy in Africa – case revisited. Clin Oncol (R Coll Radiol) 26(6):333–343. doi:10.1016/j.clon.2014.03.004, Epub 2014 Apr 18
Recommendations for use of chemotherapy for the treatment of advanced breast cancer- a clinical practice guideline developed by National Breast and Ovarian Cancer Centre (NBOCC) 2010
Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE (2008) Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 110(1):183–188, Epub 2007 Aug 3
Sayed S, Moloo Z, Wasike R, Bird P, Oigara R, Govender D, Kibera J, Carrara H, Saleh M (2014) Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya. Breast 23(5):591–596. doi:10.1016/j.breast.2014.06.006, Epub 2014 Jul 7
Burstein HJ, Prestrud AA, Seidenfeld J, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Malin J, Mamounas EP, Rowden D, Solky AJ, Sowers MR, Stearns V, Winer EP, Somerfield MR, Griggs JJ, American Society of Clinical Oncology (2010) American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 28(23):3784–3796. doi:10.1200/JCO.2009.26.3756, Epub 2010 Jul 12. Review
Murray N, Winstanley J, Bennett A, Francis K et al (2009) Diagnosis and treatment of advanced breast cancer: summary of NICE guidance. BMJ 338:b509. doi:10.1136/bmj.b509
Kristensen TB, Knutsson ML, Wehland M, Laursen BE, Grimm D, Warnke E, Magnusson NE (2014) Anti-vascular endothelial growth factor therapy in breast cancer. Int J Mol Sci 15(12):23024–23041
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ogundiran, T., Adebamowo, C. (2015). Breast Cancer. In: Droz, JP., Carme, B., Couppié, P., Nacher, M., Thiéblemont, C. (eds) Tropical Hemato-Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-18257-5_29
Download citation
DOI: https://doi.org/10.1007/978-3-319-18257-5_29
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18256-8
Online ISBN: 978-3-319-18257-5
eBook Packages: MedicineMedicine (R0)